Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials

Saved in:
Bibliographic Details
Published in:Skin (Milwood, N.Y.) N.Y.), 2022-11, Vol.6 (6), p.s67
Main Authors: Blauvelt, Andrew, Stein Gold, Linda, Gooderham, Melinda, Strober, Bruce, Pinter, Andreas, Carrascosa, Jose-Manuel, Gisondi, Paolo, Bleier, Jonathan, Madden, Cynthia, Deherder, Delphine, Gomez, Natalie Nunez, Warren, Richard B
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 6
container_start_page s67
container_title Skin (Milwood, N.Y.)
container_volume 6
creator Blauvelt, Andrew
Stein Gold, Linda
Gooderham, Melinda
Strober, Bruce
Pinter, Andreas
Carrascosa, Jose-Manuel
Gisondi, Paolo
Bleier, Jonathan
Madden, Cynthia
Deherder, Delphine
Gomez, Natalie Nunez
Warren, Richard B
description
doi_str_mv 10.25251/skin.6.supp.67
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_25251_skin_6_supp_67</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25251_skin_6_supp_67</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_25251_skin_6_supp_673</originalsourceid><addsrcrecordid>eNqVj01OwzAQhS1EJSromu1coEmcX5UdIBAHYG9NE5tMm9iWx6EK1-DCpIgF267eW7xPT58Q9zJL8iqvZMpHskmd8OR9UjdXYp1XTbmVdV5e_-s3YsN8yLIs30nZ7Mq1-H6iUR_paxpxD9oYarGdAW0HjEbHGWIf3PTRQzw5mDUGBrLgMZK2keFEsYfRdTpg1ODZBUImfoBHi8O8NHAGvHOD7qDDiGCCG8HQ5zLukTUUabGHdiC7HA8QF3zgO7EyS-jNX96K9PXl_flt2wbHHLRRPtCIYVYyU7_66qyvanXWV3VTXE78AEXHac8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials</title><source>DOAJ Directory of Open Access Journals</source><creator>Blauvelt, Andrew ; Stein Gold, Linda ; Gooderham, Melinda ; Strober, Bruce ; Pinter, Andreas ; Carrascosa, Jose-Manuel ; Gisondi, Paolo ; Bleier, Jonathan ; Madden, Cynthia ; Deherder, Delphine ; Gomez, Natalie Nunez ; Warren, Richard B</creator><creatorcontrib>Blauvelt, Andrew ; Stein Gold, Linda ; Gooderham, Melinda ; Strober, Bruce ; Pinter, Andreas ; Carrascosa, Jose-Manuel ; Gisondi, Paolo ; Bleier, Jonathan ; Madden, Cynthia ; Deherder, Delphine ; Gomez, Natalie Nunez ; Warren, Richard B</creatorcontrib><identifier>ISSN: 2574-1624</identifier><identifier>EISSN: 2574-1624</identifier><identifier>DOI: 10.25251/skin.6.supp.67</identifier><language>eng</language><ispartof>Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s67</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Blauvelt, Andrew</creatorcontrib><creatorcontrib>Stein Gold, Linda</creatorcontrib><creatorcontrib>Gooderham, Melinda</creatorcontrib><creatorcontrib>Strober, Bruce</creatorcontrib><creatorcontrib>Pinter, Andreas</creatorcontrib><creatorcontrib>Carrascosa, Jose-Manuel</creatorcontrib><creatorcontrib>Gisondi, Paolo</creatorcontrib><creatorcontrib>Bleier, Jonathan</creatorcontrib><creatorcontrib>Madden, Cynthia</creatorcontrib><creatorcontrib>Deherder, Delphine</creatorcontrib><creatorcontrib>Gomez, Natalie Nunez</creatorcontrib><creatorcontrib>Warren, Richard B</creatorcontrib><title>Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials</title><title>Skin (Milwood, N.Y.)</title><issn>2574-1624</issn><issn>2574-1624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqVj01OwzAQhS1EJSromu1coEmcX5UdIBAHYG9NE5tMm9iWx6EK1-DCpIgF267eW7xPT58Q9zJL8iqvZMpHskmd8OR9UjdXYp1XTbmVdV5e_-s3YsN8yLIs30nZ7Mq1-H6iUR_paxpxD9oYarGdAW0HjEbHGWIf3PTRQzw5mDUGBrLgMZK2keFEsYfRdTpg1ODZBUImfoBHi8O8NHAGvHOD7qDDiGCCG8HQ5zLukTUUabGHdiC7HA8QF3zgO7EyS-jNX96K9PXl_flt2wbHHLRRPtCIYVYyU7_66qyvanXWV3VTXE78AEXHac8</recordid><startdate>20221116</startdate><enddate>20221116</enddate><creator>Blauvelt, Andrew</creator><creator>Stein Gold, Linda</creator><creator>Gooderham, Melinda</creator><creator>Strober, Bruce</creator><creator>Pinter, Andreas</creator><creator>Carrascosa, Jose-Manuel</creator><creator>Gisondi, Paolo</creator><creator>Bleier, Jonathan</creator><creator>Madden, Cynthia</creator><creator>Deherder, Delphine</creator><creator>Gomez, Natalie Nunez</creator><creator>Warren, Richard B</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221116</creationdate><title>Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials</title><author>Blauvelt, Andrew ; Stein Gold, Linda ; Gooderham, Melinda ; Strober, Bruce ; Pinter, Andreas ; Carrascosa, Jose-Manuel ; Gisondi, Paolo ; Bleier, Jonathan ; Madden, Cynthia ; Deherder, Delphine ; Gomez, Natalie Nunez ; Warren, Richard B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_25251_skin_6_supp_673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blauvelt, Andrew</creatorcontrib><creatorcontrib>Stein Gold, Linda</creatorcontrib><creatorcontrib>Gooderham, Melinda</creatorcontrib><creatorcontrib>Strober, Bruce</creatorcontrib><creatorcontrib>Pinter, Andreas</creatorcontrib><creatorcontrib>Carrascosa, Jose-Manuel</creatorcontrib><creatorcontrib>Gisondi, Paolo</creatorcontrib><creatorcontrib>Bleier, Jonathan</creatorcontrib><creatorcontrib>Madden, Cynthia</creatorcontrib><creatorcontrib>Deherder, Delphine</creatorcontrib><creatorcontrib>Gomez, Natalie Nunez</creatorcontrib><creatorcontrib>Warren, Richard B</creatorcontrib><collection>CrossRef</collection><jtitle>Skin (Milwood, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blauvelt, Andrew</au><au>Stein Gold, Linda</au><au>Gooderham, Melinda</au><au>Strober, Bruce</au><au>Pinter, Andreas</au><au>Carrascosa, Jose-Manuel</au><au>Gisondi, Paolo</au><au>Bleier, Jonathan</au><au>Madden, Cynthia</au><au>Deherder, Delphine</au><au>Gomez, Natalie Nunez</au><au>Warren, Richard B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials</atitle><jtitle>Skin (Milwood, N.Y.)</jtitle><date>2022-11-16</date><risdate>2022</risdate><volume>6</volume><issue>6</issue><spage>s67</spage><pages>s67-</pages><issn>2574-1624</issn><eissn>2574-1624</eissn><doi>10.25251/skin.6.supp.67</doi></addata></record>
fulltext fulltext
identifier ISSN: 2574-1624
ispartof Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s67
issn 2574-1624
2574-1624
language eng
recordid cdi_crossref_primary_10_25251_skin_6_supp_67
source DOAJ Directory of Open Access Journals
title Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A46%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bimekizumab%20efficacy%20and%20safety%20through%20two%20years%20in%20patients%20with%20moderate%20psoriasis:%20Analysis%20of%20pooled%20data%20from%20five%20phase%203/3b%20clinical%20trials&rft.jtitle=Skin%20(Milwood,%20N.Y.)&rft.au=Blauvelt,%20Andrew&rft.date=2022-11-16&rft.volume=6&rft.issue=6&rft.spage=s67&rft.pages=s67-&rft.issn=2574-1624&rft.eissn=2574-1624&rft_id=info:doi/10.25251/skin.6.supp.67&rft_dat=%3Ccrossref%3E10_25251_skin_6_supp_67%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_25251_skin_6_supp_673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true